Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine
既往 SARS-CoV-2 感染期间的症状和接种疫苗前的血清状态影响 BNT162b2 COVID-19 mRNA 疫苗的免疫原性
期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2022.930252
Sabryna Nantel, Benoîte Bourdin, Kelsey Adams, Julie Carbonneau, Henintsoa Rabezanahary, Marie-Ève Hamelin, Deirdre McCormack, Patrice Savard, Yves Longtin, Matthew P Cheng, Gaston De Serres, Jacques Corbeil, Vladimir Gilca, Mariana Baz, Guy Boivin, Caroline Quach, Hélène Decaluwe3